Texas Comptroller Initiates Audit of Municipal Water Fluoridation Costs and Health Data

Texas State Audit Puts Fluoridation Economics Under the Microscope

The Texas Comptroller of Public Accounts has initiated a statewide review of municipal expenditures and health implications tied to water fluoridation, with the stated aim of comparing naturally occurring aquifer fluoride concentrations against the cost and health footprint of artificial supplementation. The office frames the exercise as an audit of inputs versus measured outcomes rather than a policy endorsement.

What the Review Actually Covers

According to the Comptroller's announcement, the investigation will track two parallel variables across Texas public water systems: baseline fluoride levels already present in groundwater sources, and the incremental expense utilities incur to maintain artificially adjusted concentrations. The review's stated endpoint is an assessment of potential health outcomes correlated with those expenditures. No preliminary findings, timelines, or legislative recommendations have been disclosed in the initial notice.

The review lands alongside a separate but adjacent governance signal. The Association of Metropolitan Water Agencies formally approved updated policy resolutions clarifying that decisions on community water fluoridation fall to public health officials and local elected leaders, not utility managers. The procedural clarification matters because it relocates the authority to set or rescind fluoridation policy from the agencies that implement it to the bodies that commission it.

Local Decision Points and PFAS Competition for Capital

In Washington State, the city of Cheney is using its own infrastructure ledger as the basis for reconsidering fluoridation. Local leaders cite rising replacement costs for aging treatment equipment and the need to redirect capital toward emerging PFAS contamination priorities. Formal deliberations on the program's future are scheduled for the October council meeting, with local dental advocates and city officials set to participate.

The Cheney calculus is narrower than the Texas review but methodologically compatible with it: when capital budgets are finite, every line item is evaluated against marginal health benefit, and competing contaminant priorities are forcing a reweighting of preventive allocations.

What Remains Unverified

The Comptroller's announcement does not specify the study population, the data sources for health outcome correlation, or whether the review will incorporate peer-reviewed neurodevelopmental or endocrine data sets. Until those methodological parameters are published, the audit's empirical weight cannot be assessed against existing systematic reviews on fluoride exposure and cognitive endpoints. Readers tracking the issue should watch for the Comptroller's interim disclosures, the Cheney council outcome, and any AMWA guidance on how local utilities should respond to elected-body reversals on fluoridation policy.